Did you mean
preparation

Search results - 10 results

Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.

detection and separate identification of 14 hrHPV types. Here, we present the clinical validation of the test in SurePath samples in comparison to a clinically validated reference test, the GP5 +/6+Enzyme ...

Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.

of 13 high-risk (hr) HPV s. OncoPredict HPV ® SCR (index assay) identifies HPV-16 and HPV-18 separately, 11 other hrHPV in aggregate and includes quality controls for sample adequacy, DNA extraction ...

Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.

IHC or HPV DNA PCR alone but significantly more specific than either separate test. In conclusion, p16(INK4 a) IHC is highly sensitive but moderately specific to diagnose HPV-transformed OPSCC when used ...

Genotyping for Human Papillomavirus Types 16 and 18 in Women With Minor Cervical Lesions: A Systematic Review and Meta-analysis.

separate assays. Conclusion: Testing for HPV 16/18 to triage women with minor abnormal cytology is poorly sensitive but may be useful as a second triage test after hrHPV testing, with direct referral if the woman is ...

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Vaginal Smears Validation Studies as Topic Abstract: BACKGROUND: Testing for high-risk HPV is more effective in primary cervical cancer screening than the cytological examination of a Pap smear. Separate ...

Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia.

a separate monograph entitled “Comprehensive Control of HPV Infections and Related Diseases” Vaccine Volume 30, Supplement 5, 2012. Health Topics:  Quality of healthcare Category:  A1 FOS Classification:  3.03 ...

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.

Central Asia Region” Vaccine Volume 31, Supplement 7, 2013. Updates of the progress in the field are presented in a separate monograph entitled “Comprehensive Control of HPV Infections and Related Diseases” ...

Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.

the separate effects of age, period and cohort. RESULTS: The corrected age standardized mortality rate (ASMR) decreased regularly from 9.2/100 000 in the mid 1950s to 2.5/100,000 in the late 1990s. ...

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

and a liquid-based sample were prepared from the same woman or when one or the other type of sample was taken from a separate but similar cohort. The current systematic review and meta-analysis is ...

QR code

QR code for this page URL